TREATMENT OF REFRACTORY AND RELAPSED NON-HODGKINS LYMPHOMA WITH IFOSFAMIDE, METHOTREXATE AND ETOPOSIDE

被引：7
|
作者：
SANGSTER, G
PATTON, WN
HARRIS, RI
GRIEVE, RJ
LEYLAND, MJ
机构：
[1] E BIRMINGHAM HOSP,DEPT CLIN HAEMATOL,BIRMINGHAM B9 5ST,W MIDLANDS,ENGLAND
[2] WALSGRAVE HOSP,DEPT HAEMATOL,COVENTRY CV2 2DY,W MIDLANDS,ENGLAND
[3] COVENTRY & WARWICKSHIRE HOSP,DEPT RADIOTHERAPY,COVENTRY CV1 4FH,W MIDLANDS,ENGLAND
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 23卷 / 04期
关键词：
D O I：
10.1007/BF00451654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [1] TREATMENT OF RELAPSED NON-HODGKINS LYMPHOMA WITH A COMBINATION OF HYDROXYUREA, IFOSFAMIDE, AND ETOPOSIDE
    GASSER, AB
    STEWARD, WP
    WAGSTAFF, J
    SCARFFE, JH
    CROWTHER, D
    CANCER TREATMENT REPORTS, 1985, 69 (02): : 225 - 226
  • [2] TREATMENT OF REFRACTORY AND RELAPSED NON-HODGKINS-LYMPHOMA (NHL) WITH IFOSFAMIDE (I), METHOTREXATE (M) AND ETOPOSIDE (VP16)
    SANGSTER, G
    LEYLAND, MJ
    BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 345 - 345
  • [3] LOMUSTINE, ETOPOSIDE, METHOTREXATE AND PREDNISONE (LEMP) THERAPY FOR RELAPSED AND REFRACTORY NON-HODGKINS-LYMPHOMA
    DORIGO, A
    MANSBERG, R
    KWAN, YL
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 50 (01) : 37 - 40
  • [4] Lenalidomide in relapsed refractory non-Hodgkins lymphoma: An Indian perspective
    Lakshmaiah, K. C.
    Shetty, K. S. Rachan
    Sathyanarayanan, Vishwanath
    Lokanatha, D.
    Abraham, Linu Jacob
    Babu, K. Govinda
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04) : 857 - 861
  • [5] Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma
    Stamatoullas, A
    Fruchart, C
    Bastit, D
    Boulet, D
    Monconduit, M
    Piguet, H
    Tilly, H
    CANCER, 1996, 77 (11) : 2302 - 2307
  • [6] A phase I and translational study of topotecan-etoposide combination in relapsed or refractory non-Hodgkins lymphoma.
    Kancherla, R
    Nair, J
    Durrani, H
    Dinh, YT
    Valimohd, A
    Seiter, K
    Feldman, E
    Navone, J
    Das, A
    Ahmed, T
    BLOOD, 1998, 92 (10) : 237B - 237B
  • [7] IFOSFAMIDE, EPIRUBICIN AND ETOPOSIDE (IEV) THERAPY IN RELAPSED AND REFRACTORY HIGH-GRADE NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    ZINZANI, PL
    BARBIERI, E
    VISANI, G
    GHERLINZONI, F
    PERINI, F
    NERI, S
    BENDANDI, M
    AMMENDOLIA, I
    SALVUCCI, M
    BABINI, L
    TURA, S
    HAEMATOLOGICA, 1994, 79 (06) : 508 - 512
  • [8] INFUSION OF ETOPOSIDE AND VINCRISTINE IN NON-HODGKINS LYMPHOMA
    JACKSON, DV
    POWELL, BL
    CRUZ, JM
    SPURR, CL
    MUSS, HB
    SELECTIVE CANCER THERAPEUTICS, 1989, 5 (03): : 129 - 136
  • [9] ETOPOSIDE, CARMUSTINE, BLEOMYCIN, AND METHOTREXATE WITH LEUCOVORIN RESCUE AS RE-TREATMENT FOR UNFAVORABLE NON-HODGKINS LYMPHOMA
    HELMS, SR
    OBLON, DJ
    BRAYLAN, RC
    WEINER, RS
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 783 - 786
  • [10] Rituximab and CHOP treatment in relapsed lowgrade non-Hodgkins lymphoma
    Mihaescu, R
    Iordache, M
    Vasile, K
    Ionita, H
    ANNALS OF ONCOLOGY, 2005, 16 : 154 - 155
12345